Kodiak Sciences Inc.

NASDAQ:KOD

Biotechnology

Healthcare
$97.81 -0.08%

-$0.03 today

Market cap
$6.40B
Beta
2.21
P/E (TTM)
-9.6
EPS (TTM)
-$3.73
52W Low $3.43High $47.84

Volume 0.74M

Average 1.10M

Fair Value & DCF

Compare our fair value with your own assumptions

Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.

Kodiak Sciences Inc.

NASDAQ:KOD

Intrinsic Alpha fair value

Locked

Current Price

$97.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.

Build your own valuation

Test an independent scenario and compare it with Intrinsic Alpha's estimate.

Sign in to use the DCF calculator

Free accounts get 5 valuations per week. Upgrade for more.

Sign in / Sign up

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
N/A2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Estimates & History

Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.

Further estimates hidden. Sign in to unlock

Competitor Valuations

Peer stocks ranked by intrinsic value status

CompanyMarket CapPriceValuationP/E1Y Return

Regeneron Pharmaceuticals, Inc.

NASDAQ:REGN

$98.82B$955.47Undervalued14.2+35.08%

Bausch + Lomb Corporation

NYSE:BLCO

$7.54B$21.09Overvalued-24.2+43.30%

Belite Bio, Inc

NASDAQ:BLTE

$6.62B$164.36Not rated-65.9+29.79%

Ocular Therapeutix, Inc.

NASDAQ:OCUL

$1.37B$6.21Not rated-7.3-50.91%

4D Molecular Therapeutics, Inc.

NASDAQ:FDMT

$675.64M$12.23Not rated-4.0-3.15%

Oculis Holding AG

NASDAQ:OCS

$471.63M$7.64Not rated-5.5-61.65%

Ocugen, Inc.

NASDAQ:OCGN

$280.88M$0.83Not rated-5.6-35.16%

Outlook Therapeutics, Inc.

NASDAQ:OTLK

$100.54M$0.41Not rated-2.1-79.19%

EyePoint Pharmaceuticals, Inc.

NASDAQ:EYPT

$25.66M$0.31Not rated-4.2-79.06%